Dronabinol

Product manufactured by Akorn, Inc.

Application Nr Approved Date Route Status External Links
ANDA079217 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Dronabinol Capsules Are Indicated In Adults For The Treatment Of: Anorexia Associated With Weight Loss In Patients With Acquired Immune Deficiency Syndrome (Aids). Nausea And Vomiting Associated With Cancer Chemotherapy In Patients Who Have Failed To Respond Adequately To Conventional Antiemetic Treatments. Dronabinol Capsules Is A Cannabinoid Indicated In Adults For The Treatment Of: Anorexia Associated With Weight Loss In Patients With Aids. ( 1 ) Nausea And Vomiting Associated With Cancer Chemotherapy In Patients Who Have Failed To Respond Adequately To Conventional Antiemetic Treatments. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Dronabinol DRONABINOL ZINC1530625

Comments